Detalles de la búsqueda
1.
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review.
Qual Life Res
; 31(3): 645-657, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283382
2.
Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations.
J Med Internet Res
; 24(1): e25792, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014969
3.
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
Stroke
; 51(7): 2066-2075, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539675
4.
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study.
J Med Internet Res
; 22(9): e19694, 2020 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915159
5.
Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.
BMC Cancer
; 18(1): 1013, 2018 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348130
6.
Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.
Europace
; 18(4): 501-7, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26718532
7.
Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.
Thromb J
; 14: 4, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26900350
8.
Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
J Stroke Cerebrovasc Dis
; 23(2): e73-83, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24119623
9.
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
BMC Health Serv Res
; 13: 456, 2013 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-24176086
10.
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France.
J Med Econ
; 26(1): 243-253, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36705644
11.
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.
Ther Adv Med Oncol
; 15: 17588359231152847, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743523
12.
Organizational Impact of Immunotherapies in Advanced Cancers in France.
JCO Glob Oncol
; 9: e2300026, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595168
13.
Characteristics, management, and healthcare resources of patients with advanced non-small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis.
Respir Med Res
; 84: 101051, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897879
14.
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France.
Eur J Health Econ
; 24(6): 867-875, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36030485
15.
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.
World J Urol
; 30(3): 419-26, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21892656
16.
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.
J Med Econ
; 25(1): 691-699, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35587018
17.
Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study.
Arch Cardiovasc Dis
; 115(11): 571-577, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257903
18.
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.
JCO Clin Cancer Inform
; 6: e2100108, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113656
19.
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts.
Cancers (Basel)
; 14(24)2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551632
20.
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.
BMC Health Serv Res
; 11: 151, 2011 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21702989